The latest psychedelic drug company to commence public trading is Psyched Wellness.
Articles
Mind Cure Announces LOI for Acquisition of Epiphany360 Digital Therapeutics Platform for Treating Mental Health
Mind Cure has acquired Epiphany360, a digital therapeutics platform for the treatment of mental health conditions.
State And Local Marijuana Regulators Demand Congress Prioritize Federal Legalization Bill
A coalition of state and local marijuana regulators sent a letter to House leadership on Wednesday, demanding that they prioritize a marijuana legalization bill that’s expected to get a floor vote following the election.
Massachusetts Approves Expanded Cannabis Delivery Licensing
The Massachusetts Cannabis Control Commission on Tuesday approved regulations for expanded cannabis home delivery, the Boston Globe reports.
New Survey Underscores Strong Support For Cannabis Among NJ Voters
New Jersey is poised to join the growing number of states to legalize recreational marijuana use when voters head to the polls next month, according to a new survey out this week.
Top Senate Democrat Includes Marijuana Banking Protections In New Coronavirus Relief Bill
The top Democrat in the Senate introduced a coronavirus relief bill on Monday that contains provisions to protect banks that service state-legal marijuana businesses from being penalized by federal regulators.
Marijuana Legalization In Texas Would Generate Billions In Tax Revenue, New Economic Analysis Shows
Texas stands to generate billions of dollars in marijuana tax revenue and create tens of thousands of jobs if the plant is legalized, according to a new economic analysis.
Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson's Disease
Pharmather is seeking to advance a ketamine-based therapy for the treatment of Parkinson's disease.
Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds
Revive has signed a psychedelics supply agreement with HAVN Life Sciences.
Why Psychedelic Stocks Are A Strong Hedge Against COVID-19 Risk
Psychedelic drug stocks may represent the best investing strategy to hedge against COVID-19 economic risks.
Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO
Cybin Corp. announces it has closed on an oversubscribed private placement of CAD$45 million as it prepares to go public.
New York Will Legalize Marijuana By April And Regulate CBD-Infused Drinks, Governor’s Advisor Says
The top marijuana advisor to New York Gov. Andrew Cuomo (D) says cannabis legalization legislation will again be introduced through the state budget in January, with the goal being to enact the reform by April
35 US Senate seats are up for grabs, and several would be key wins for the cannabis sector
The business outlook for cannabis companies could be significantly different this time next year, depending in large part on which party controls the Senate and which senators are elected.
USDA Approves Hemp Plans For Six Additional States And Three Indian Tribes
The U.S. Department of Agriculture (USDA) has signed off on hemp plans for six additional states and three Indian tribes this month, with a new batch of approvals coming on Friday.
Will MindMed NASDAQ Listing Be The Next Sector-Wide Catalyst?
The Compass Pathways IPO was a huge catalyst for the whole sector. Will a MindMed up-listing have the same impact?